3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Vasculitis, Central Nervous System
1
Stiff-Person Syndrome
1
Rasmussen subacute encephalitis
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Plasmablastic Lymphoma
1
Opsoclonus-Myoclonus Syndrome
1
Neuromyelitis Optica
1
Myasthenia Gravis
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lambert-Eaton Myasthenic Syndrome
1
Hodgkin Disease
1
HIV Infections
1
Burkitt Lymphoma
1
Brain Neoplasms
1
Autoimmune Diseases of the Nervous System
1
Autoimmune Diseases
1
Interventions
ruxolitinib
3
venetoclax
2
fludarabine phosphate
2
duvelisib
2
thymoglobulin
1
romidepsin
1
itacitinib
1
fludarabine
1
Whole-Body Irradiation
1
Stem Cell Transplantation
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Lisaftoclax
1
Depsipeptides
1
Cyclosporins
1
Cyclosporine
1
Cladribine
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Prolymphocytic, T-Cell
×
carmustine, poliferprosan 20 drug combination
×
1 year
×
Clear all
No trials found.